透過您的圖書館登入
IP:18.226.181.89
  • 期刊
  • OpenAccess

The Molecular Mechanisms for Arteriovenous Fistula Failure and the Corresponding Therapies

並列摘要


Native arteriovenous fistula (AVF) accounts for the majority of vascular access for hemodialysis (HD) patients in Taiwan. Vascular access dysfunction causes significant clinical morbidity in HD patients. Venous stenosis that results from neointimal hyperplasia is the most common cause of vascular access dysfunction in an AVF. The exact molecular mechanisms underlying the formation of venous stenosis in AVF failure are poorly understood. Many molecular pathways that are associated with oxidative stress, inflammation, angiogenesis and endothelial dysfunction have been hypothesized to cause progressive venous stenos is. Although many studies have implicated the venous stenosis mechanism, few strategies can effectively prevent vascular access failure in HD patients. This review describes the important molecular pathways for hemodialysis access stenosis and presents potential preventive therapies for AVF failure. It is hoped that this paper will lead to effective preventive treatments for AVF dysfunction in the future.

參考文獻


56. Ko W-S, Chen T-H, Chen C-H, Chen T-W, Chen Y-C. Non-thermal effect of far-infrared activates Akt to reduce doxorubicin-induced apoptosis in human umbilical vein endothelial cells. Acta Nephro-logica 26: 2-7, 2012.
62. Porter, KE Naik J, Turner NA, Dickinson T, Thompson MM, London NJ. Simvastatin inhibits human saphenous vein neointi-ma formation viainhibition of smooth muscle cell proliferation and migration.J Vasc Surg36: 150-157, 2002.
63. Turner NA, O'Regan DJ, Ball SG, Porter KE. Simvastatin inhib-its MMP-9 secretion from human saphenous vein smooth muscle cells by inhibiting the RhoA/ROCK pathway and reducing MMP-9 mRNA levels. FASEB J 19: 804-806, 2005.
64. Janardhanan R, Yang B, Vohra P, Roy B, Withers S, Bhattacharya S, et al. Simvastatin reduces venous stenosis formation in a murine hemodialysis vascular access model. Kidney Int84: 338-352, 2013.
65. Turner NA, Midgley L, O'Regan DJ, Porter KE. Comparison of the efficacies of five different statins on inhibition of human saphenous vein smooth muscle cell proliferation and invasion. J Cardiovasc Pharmacol50: 458-461, 2007.

延伸閱讀